Mobile

A Phase II/III, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of atacicept in combination with corticosteroids and sequential therapy with cyclophosphamide and...

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-002221-36

A Phase II/III, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of atacicept in combination with corticosteroids and sequential therapy with cyclophosphamide and azathioprine in subjects with lupus nephritis

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

PRIMARY The primary objective of this trial is to evaluate the efficacy of atacicept compared to placebo in subjects with active LN who are receiving corticosteroids and sequential therapy with cyclophosphamide (CY) and azathioprine (AZA).

Critère d'inclusion

  • Lupus Nephritis

Liens